melphalan

简明释义

英[ˈmelfəˌlæn]美[ˈmelfələn]

n. 美法仑；左旋溶肉瘤素

英英释义

单词用法

同义词

反义词

例句

1.The common side effect in intravenous melphalan is mucositis.

黏膜炎是静脉马法兰应用后最常见的副反应；

2.Methods Retrospective analysis for autologous transplant mainly with intravenous melphalan in 43 children with advanced malignant solid tumours was performed in our center.

方法用回顾性分析的方法，对43例以静脉马法兰为主的预处理移植治疗的儿童高危恶性肿瘤临床资料进行分析。

3.Methods Retrospective analysis for autologous transplant mainly with intravenous melphalan in 43 children with advanced malignant solid tumours was performed in our center.

方法用回顾性分析的方法，对43例以静脉马法兰为主的预处理移植治疗的儿童高危恶性肿瘤临床资料进行分析。

4.The clinical trial showed promising results for melphalan in combination with other therapies.

临床试验显示美法仑与其他疗法联合使用有良好的效果。

5.The pharmacist explained how melphalan works to inhibit cancer cell growth.

药剂师解释了美法仑如何抑制癌细胞生长。

6.After discussing the side effects, the doctor recommended melphalan as a viable option.

在讨论副作用后，医生推荐了美法仑作为一个可行的选择。

7.Patients receiving melphalan should be monitored for potential liver toxicity.

接受美法仑治疗的患者应监测潜在的肝毒性。

8.The oncologist prescribed melphalan for the patient's multiple myeloma treatment.

肿瘤科医生为患者的多发性骨髓瘤治疗开了美法仑。

作文

In the realm of oncology, various treatments are employed to combat cancer, and one such treatment is a drug known as melphalan. This medication belongs to a class of drugs called alkylating agents, which work by interfering with the DNA of cancer cells, ultimately preventing them from dividing and growing. The use of melphalan is particularly prominent in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. Patients diagnosed with this condition often face a challenging journey, and the introduction of melphalan into their treatment regimen can offer hope for better outcomes.The history of melphalan dates back to the mid-20th century when it was first developed. Since then, it has undergone numerous studies to evaluate its efficacy and safety. Clinical trials have shown that melphalan can be effective in reducing tumor size and improving survival rates in patients with multiple myeloma. However, like all medications, it comes with potential side effects, including nausea, vomiting, and a decrease in blood cell counts, which necessitates careful monitoring by healthcare professionals.One of the unique aspects of melphalan is its ability to be administered in different ways. It can be given orally or intravenously, depending on the patient’s condition and the specific treatment plan. This flexibility allows oncologists to tailor therapies to individual needs, optimizing the chances of a successful outcome. For instance, in some cases, melphalan may be used in combination with other drugs to enhance its effectiveness, a strategy known as combination therapy. Such approaches have become increasingly common in oncology, as they can lead to more comprehensive treatment strategies.Furthermore, research continues to explore the potential of melphalan beyond multiple myeloma. Studies are being conducted to assess its effectiveness in treating other types of cancers, such as ovarian cancer and certain forms of leukemia. This ongoing research is crucial, as it could expand the utility of melphalan and provide more options for patients facing difficult diagnoses.In conclusion, melphalan is a vital component in the arsenal against cancer, particularly for those battling multiple myeloma. Its historical significance, combined with its adaptability in treatment plans and ongoing research, underscores its importance in modern oncology. As new findings emerge, the role of melphalan may evolve, offering hope to many patients who seek effective cancer treatments. Understanding the implications of melphalan not only enhances our knowledge of cancer therapies but also highlights the continuous advancements in medical science aimed at improving patient care and outcomes.

在肿瘤学领域，各种治疗方法被用来对抗癌症，其中一种药物被称为melphalan。这种药物属于烷化剂类药物，通过干扰癌细胞的DNA，最终阻止它们分裂和生长。melphalan的使用在多发性骨髓瘤的治疗中尤为突出，这是一种影响浆细胞的血癌。被诊断为这种疾病的患者往往面临艰难的旅程，而将melphalan引入他们的治疗方案可以为更好的结果提供希望。melphalan的历史可以追溯到20世纪中叶，当时它首次被开发出来。从那时起，它经历了无数研究，以评估其疗效和安全性。临床试验表明，melphalan能够有效减少肿瘤大小，提高多发性骨髓瘤患者的生存率。然而，像所有药物一样，它也伴随着潜在的副作用，包括恶心、呕吐和血细胞计数下降，这需要医疗专业人员的仔细监测。melphalan的一个独特之处在于它可以通过不同的方式给药。根据患者的状况和具体的治疗计划，它可以口服或静脉注射。这种灵活性使肿瘤科医生能够根据个人需求量身定制治疗方案，优化成功结果的机会。例如，在某些情况下，melphalan可能与其他药物联合使用，以增强其有效性，这种策略被称为联合治疗。这种方法在肿瘤学中变得越来越普遍，因为它可以导致更全面的治疗策略。此外，研究还在继续探索melphalan在多发性骨髓瘤以外的潜力。正在进行的研究旨在评估它在治疗其他类型癌症（如卵巢癌和某些类型白血病）中的有效性。这项持续的研究至关重要，因为它可能扩大melphalan的应用，并为面临困难诊断的患者提供更多选择。总之，melphalan是对抗癌症的重要组成部分，特别是对那些与多发性骨髓瘤作斗争的人。它的历史意义，加上其在治疗方案中的适应性和持续的研究，凸显了它在现代肿瘤学中的重要性。随着新发现的出现，melphalan的角色可能会发展，为许多寻求有效癌症治疗的患者带来希望。理解melphalan的含义不仅增强了我们对癌症治疗的认识，还突显了医学科学在改善患者护理和结果方面的持续进步。